Ultragenyx Pharmaceutical Inc. (RARE)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Alkeon Capital Management

Panayotis Takis Sparaggis

1,313,857 $149,595 +1% 0.22%
2. 944,513 $107,542 +87% 0.02%
3.
D E Shaw

D. E. Shaw

751,168 $85,528 +6% 0.08%
4.
Rock Springs Capital Management

Kris Jenner, Gordon Bussard, Graham Mcphail

450,000 $51,237 -21% 1.11%
5.
Baker Bros. Advisors

Julian Baker And Felix Baker

444,444 $50,604 0.21%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$43.63 5,000 Officer, Director 472,479 2019-09-11 Filing
$52.96 1,647 Officer, Director 2,559,741 2017-08-28 Filing
$52.40 5,853 Officer, Director 2,558,094 2017-08-28 Filing
$21.00 175,000 Large Shareholder, Other 3,260,240 2014-01-31 Filing
$21.00 4,500 Officer 84,255 2014-01-30 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$94.96 572 Officer 25,708 2021-06-21 Filing
$94.63 437 Officer 26,280 2021-06-19 Filing
$100.00 1,329 Officer 28,668 2021-06-10 Filing
$113.67 364 Officer 38,775 2021-05-06 Filing
$113.67 393 Officer 26,717 2021-05-07 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 72,517 $8,256,787 0%
2. 50,571 $5,758,014 0.06%
3. 38,549 $4,389,189 0%
4. 10,671,786 $1,215,090 0.12%
5. 7,373,873 $839,589 0.2%
News See All